SENP1
SENP1 (Sentrin/SUMO-specific protease 1) is a protein that in humans is encoded by the SENP1 gene. SENP1 is a member of the SUMO (Small Ubiquitin-like Modifier) specific protease family, which plays a critical role in the post-translational modification of proteins. This enzyme is involved in the processing of SUMO precursors as well as in the deconjugation of SUMO from targeted proteins, thereby regulating the SUMO pathway. The SUMO pathway is essential for the regulation of numerous biological processes, including transcription, DNA repair, cell cycle progression, and signal transduction.
Function[edit | edit source]
SENP1 is primarily involved in the maturation of SUMO precursors and the deconjugation of SUMO from target proteins. By cleaving off SUMO from proteins, SENP1 regulates their function, localization, and stability, impacting various cellular processes. The enzyme's activity is crucial for maintaining cellular homeostasis and responding to stress conditions. SENP1 has been shown to play a significant role in the regulation of transcription factors, nuclear transport, and the maintenance of genome stability.
Clinical Significance[edit | edit source]
Alterations in SENP1 expression and activity have been linked to several human diseases, including cancer, heart disease, and neurodegenerative diseases. Overexpression of SENP1 has been observed in various types of cancer, where it is thought to contribute to tumorigenesis by deregulating SUMOylation-dependent pathways. Conversely, reduced SENP1 activity has been associated with cardiovascular diseases and neurodegeneration, suggesting a protective role of SENP1 in these conditions.
Research[edit | edit source]
Research on SENP1 has focused on understanding its substrate specificity, regulation, and role in disease. Studies have explored the development of SENP1 inhibitors as potential therapeutic agents for cancer and other diseases where SENP1 is dysregulated. Additionally, research aims to elucidate the broader implications of SUMOylation and SENP1 activity in cellular physiology and pathology.
See Also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
